Fresenius Medical Care Achieves 25x Faster Kidney Disease Insights with Privacy Analytics

1. Faster Insights: Fresenius Medical Care, a leading provider of products and services for end-stage kidney disease, has achieved 25 times faster insights into kidney disease using Privacy Analytics, reducing the time to gather and analyze data from six months to less than a week.
2. Global Database: The company created the world’s largest longitudinal database of clinical dialysis information, known as Apollo Dial DB, which includes data from over 540,000 patients across more than 40 countries.
3. Privacy Compliance: The database adheres to a complex set of global, regional, and local privacy requirements, including HIPAA and GDPR, ensuring the data is fully anonymized and secure.
4. Improved Care: The faster insights and access to a large pool of patient data have enabled Fresenius Medical Care to launch 15 clinical improvement projects, including expanding the Anemia Control Model and characterizing medication patterns across six continents.
5. Broader Impact: The Apollo Dial DB is expected to become a valuable resource for the broader medical community, allowing third parties to perform analytics under specific agreements, contributing to advancing care for people with end-stage kidney disease.